<DOC>
	<DOCNO>NCT00897247</DOCNO>
	<brief_summary>RATIONALE : Studying sample body fluid blood patient expose asbestos vermiculite laboratory may help doctor learn change may occur DNA identify biomarkers related cancer . PURPOSE : This laboratory study look biomarkers detect mesothelioma early patient expose asbestos vermiculite .</brief_summary>
	<brief_title>Biomarkers Detect Mesothelioma Early Patients Exposed Asbestos Vermiculite</brief_title>
	<detailed_description>OBJECTIVES : - Identify patient know asbestos exposure early stage disease development ( i.e. , indolent premalignant pleural plaque fibrosis vs malignant pleural mesothelioma ) . - Determine expression level tumor-associated protein patient . - Analyze sample serum pleural effusion obtain patient . - Determine proteomic profile sample obtain patient . - Determine molecular mechanism associate regulation extracellular matrix microenvironment protein ( e.g. , osteonectin , intelectin , matrix metalloproteins ) involve disease onset progression . OUTLINE : This multicenter study . Patients undergo collection body cavity fluid , include pleural effusion , blood . Specimens , include fresh frozen malignant pleural mesothelioma tumor tissue , available , analyzed proteomic profile , gene expression profile , tumor-associated protein expression level . PROJECTED ACCRUAL : A total 200 patient accrue study .</detailed_description>
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Exposure vermiculite asbestos insulation Symptomatic nonsymptomatic exposurerelated disease Seen clinic Libby , Montana ( CARD Clinic ) Michigan ( COEM ) PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>malignant mesothelioma</keyword>
	<keyword>pulmonary complication</keyword>
</DOC>